Rapid Micro Biosystems (RPID) Income towards Parent Company (2020 - 2026)

Rapid Micro Biosystems (RPID) reported Income towards Parent Company of -$14.3 million for Q1 2026, down 26.74% on a YoY basis from -$19.5 million in Q1 2025, and down 14.23% sequentially from -$12.5 million in Q4 2025.

Rapid Micro Biosystems (RPID) Income towards Parent Company (2020 - 2026) Analysis & Trends

Rapid Micro Biosystems (RPID) has 7 years of Income towards Parent Company data on file, last reported at -$14.3 million in Q1 2026.

  • For the quarter ending Q1 2026, Income towards Parent Company fell 26.74% year-over-year to -$14.3 million; the trailing twelve-month figure through Mar 2026 stood at -$50.1 million (down 11.83% YoY), and the FY2025 full-year result was -$47.1 million, changed 0.5% from the prior year.
  • Income towards Parent Company eased to -$14.3 million in Q1 2026, from -$12.5 million in the prior quarter.
  • In the past five years, Income towards Parent Company ranged from a high of -$9.7 million in Q4 2024 to a low of -$16.5 million in Q4 2022.
  • A 5-year average of -$13.0 million and a median of -$13.1 million in 2022 frame the typical range for Income towards Parent Company.
  • Across the five-year window, Income towards Parent Company jumped 34.61% in 2022 and retreated 29.29% in 2025, its largest moves.
  • Tracing RPID's Income towards Parent Company over 5 years: stood at -$16.5 million in 2022, then jumped by 32.14% to -$11.2 million in 2023, then climbed by 13.48% to -$9.7 million in 2024, then fell by 29.29% to -$12.5 million in 2025, then fell by 14.23% to -$14.3 million in 2026.
  • Business Quant data shows RPID's Income towards Parent Company at -$14.3 million in Q1 2026, -$12.5 million in Q4 2025, and -$11.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn
8 Smith & Nephew 26.99 Bn 26.41 Bn -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn
10 Rapid Micro Biosystems 89.73 Mn 80.30 Mn 371,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -14.28 Mn
Dec 31, 2025 -12.50 Mn
Sep 30, 2025 -11.51 Mn
Jun 30, 2025 -11.86 Mn
Mar 31, 2025 -11.26 Mn
Dec 31, 2024 -9.67 Mn
Sep 30, 2024 -11.32 Mn
Jun 30, 2024 -12.58 Mn
Mar 31, 2024 -13.32 Mn
Dec 31, 2023 -11.17 Mn
Sep 30, 2023 -13.39 Mn
Jun 30, 2023 -14.02 Mn
Mar 31, 2023 -13.89 Mn
Dec 31, 2022 -16.46 Mn
Sep 30, 2022 -16.34 Mn
Jun 30, 2022 -13.10 Mn
Mar 31, 2022 -14.93 Mn
Dec 31, 2021 -14.61 Mn
Sep 30, 2021 -24.99 Mn
Jun 30, 2021 -11.83 Mn